Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
10 2019
Historique:
received: 06 05 2019
accepted: 06 09 2019
entrez: 2 10 2019
pubmed: 2 10 2019
medline: 6 2 2020
Statut: epublish

Résumé

Physical exercise has been shown to be effective in relation to fatigue, aerobic fitness, and lower body strength in men with prostate cancer. However, research into the clinically relevant effects of interventions conducted in heterogeneous patient populations and in real-life clinical practice settings is warranted. We conducted a pragmatic, multicentre, parallel randomised controlled trial in 5 Danish urological departments. Recruitment began in May 2015, the first participant was randomised in June 2015, and the last participant was included in February 2017. In total, 214 men with prostate cancer were randomly assigned to either 6 months of free-of-charge football training twice weekly at a local club (football group [FG]) (n = 109) or usual care (usual care group [UG]) (n = 105), including brief information on physical activity recommendations at randomisation. Participants were on average 68.4 (SD 6.2) years old, 157 (73%) were retired, 87 (41%) were on castration-based treatment, 19 (9%) had received chemotherapy, and 41 (19%) had skeletal metastases at baseline. In this 1-year follow-up study, we evaluated the effects of community-based football training on the following outcomes: primary outcome, quality of life; secondary outcomes: continuation of football after 6 months, hip and lumbar spine bone mineral density (BMD), mental health score, fat and lean body mass, and safety outcomes, i.e., fractures, falls, and hospital admissions. Intention to treat (ITT) and per protocol (PP) analyses were conducted. No statistically significant between-group difference was observed in change in prostate-cancer-specific quality of life (ITT: 1.9 points [95% CI -1.9 to 5.8], p = 0.325; PP: 3.6 points [95% CI -0.9 to 8.2], p = 0.119). A statistically significant between-group difference was observed in change in total hip BMD, in favour of FG (0.007 g/cm2 [95% CI 0.004 to 0.013], p = 0.037). No differences were observed in change in lumbar spine BMD or lean body mass. Among patients allocated to football, 59% chose to continue playing football after the end of the 6-month intervention period. At 1-year follow-up in the PP population, FG participants had more improvement on the Mental Component Summary (2.9 [95% CI 0.0 to 5.7], p = 0.048 points higher) than UG participants, as well as a greater loss of fat mass (-0.9 kg [95% CI -1.7 to -0.1], p = 0.029). There were no differences between groups in relation to fractures or falls. Hospital admissions were more frequent in UG compared to FG (33 versus 20; the odds ratio based on PP analysis was 0.34 for FG compared to UG). There were 3 deaths in FG and 4 in UG. Main limitations of the study were the physically active control group and assessment of physical activity by means of self-report. In this trial, participants allocated to football appeared to have improved hip BMD and fewer hospital admissions. Men who played football more than once a week for 1 year lost fat mass and reported improved mental health. Community-based football proved to be acceptable, even when club membership was not subsidised. ClinicalTrials.gov NCT02430792.

Sections du résumé

BACKGROUND
Physical exercise has been shown to be effective in relation to fatigue, aerobic fitness, and lower body strength in men with prostate cancer. However, research into the clinically relevant effects of interventions conducted in heterogeneous patient populations and in real-life clinical practice settings is warranted.
METHODS AND FINDINGS
We conducted a pragmatic, multicentre, parallel randomised controlled trial in 5 Danish urological departments. Recruitment began in May 2015, the first participant was randomised in June 2015, and the last participant was included in February 2017. In total, 214 men with prostate cancer were randomly assigned to either 6 months of free-of-charge football training twice weekly at a local club (football group [FG]) (n = 109) or usual care (usual care group [UG]) (n = 105), including brief information on physical activity recommendations at randomisation. Participants were on average 68.4 (SD 6.2) years old, 157 (73%) were retired, 87 (41%) were on castration-based treatment, 19 (9%) had received chemotherapy, and 41 (19%) had skeletal metastases at baseline. In this 1-year follow-up study, we evaluated the effects of community-based football training on the following outcomes: primary outcome, quality of life; secondary outcomes: continuation of football after 6 months, hip and lumbar spine bone mineral density (BMD), mental health score, fat and lean body mass, and safety outcomes, i.e., fractures, falls, and hospital admissions. Intention to treat (ITT) and per protocol (PP) analyses were conducted. No statistically significant between-group difference was observed in change in prostate-cancer-specific quality of life (ITT: 1.9 points [95% CI -1.9 to 5.8], p = 0.325; PP: 3.6 points [95% CI -0.9 to 8.2], p = 0.119). A statistically significant between-group difference was observed in change in total hip BMD, in favour of FG (0.007 g/cm2 [95% CI 0.004 to 0.013], p = 0.037). No differences were observed in change in lumbar spine BMD or lean body mass. Among patients allocated to football, 59% chose to continue playing football after the end of the 6-month intervention period. At 1-year follow-up in the PP population, FG participants had more improvement on the Mental Component Summary (2.9 [95% CI 0.0 to 5.7], p = 0.048 points higher) than UG participants, as well as a greater loss of fat mass (-0.9 kg [95% CI -1.7 to -0.1], p = 0.029). There were no differences between groups in relation to fractures or falls. Hospital admissions were more frequent in UG compared to FG (33 versus 20; the odds ratio based on PP analysis was 0.34 for FG compared to UG). There were 3 deaths in FG and 4 in UG. Main limitations of the study were the physically active control group and assessment of physical activity by means of self-report.
CONCLUSIONS
In this trial, participants allocated to football appeared to have improved hip BMD and fewer hospital admissions. Men who played football more than once a week for 1 year lost fat mass and reported improved mental health. Community-based football proved to be acceptable, even when club membership was not subsidised.
TRIAL REGISTRATION
ClinicalTrials.gov NCT02430792.

Identifiants

pubmed: 31574097
doi: 10.1371/journal.pmed.1002936
pii: PMEDICINE-D-19-01592
pmc: PMC6771996
doi:

Banques de données

ClinicalTrials.gov
['NCT02430792']

Types de publication

Journal Article Multicenter Study Pragmatic Clinical Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1002936

Déclaration de conflit d'intérêts

I have read the journal's policy and one author of this manuscript have the following competing interests: PK has received funding for other research activities from the DBU, Union of European Football Associations (UEFA) and FIFA in the previous 3 years. No other relationships or activities could have influenced the submitted work.

Références

Eur Urol. 2016 Apr;69(4):693-703
pubmed: 26632144
Bone. 1996 Jan;18(1 Suppl):37S-43S
pubmed: 8717546
Eur Urol. 2016 Oct;70(4):576-585
pubmed: 26774959
J Clin Oncol. 2009 Jan 20;27(3):344-51
pubmed: 19064985
Sports Med. 2010 Jul 1;40(7):565-600
pubmed: 20545381
N Engl J Med. 2017 Oct 5;377(14):1391-1398
pubmed: 28976864
Eur Urol. 2017 Dec;72(6):931-939
pubmed: 28711382
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Urology. 1997 Dec;50(6):920-8
pubmed: 9426724
Eur Urol. 2014 May;65(5):856-64
pubmed: 24113319
Can Assoc Radiol J. 2013 Nov;64(4):281-94
pubmed: 24314581
Lancet. 2016 Sep 24;388(10051):1337-48
pubmed: 27475273
Sci Rep. 2018 May 30;8(1):8374
pubmed: 29849032
J Sports Sci. 1998 Apr;16(3):211-34
pubmed: 9596356
Med Sci Sports Exerc. 2014 Aug;46(8):1482-8
pubmed: 24500540
J Clin Oncol. 2014 Feb 1;32(4):271-2
pubmed: 24344219
Cancer. 2015 Dec 15;121(24):4286-99
pubmed: 26372364
Ann Intern Med. 2013 Oct 15;159(8):560-2
pubmed: 24018844
Eur Urol. 2014 Nov;66(5):841-8
pubmed: 24954793
Eur Urol. 2015 May;67(5):825-36
pubmed: 25097095
BMC Cancer. 2016 Oct 3;16(1):767
pubmed: 27716218
Eur Urol. 2017 Aug;72(2):293-299
pubmed: 28249801
Sports Med. 2019 Jan;49(1):145-158
pubmed: 30506427
J Clin Epidemiol. 1998 Nov;51(11):1171-8
pubmed: 9817135
Osteoporos Int. 2016 Apr;27(4):1507-1518
pubmed: 26572756
Eur J Cancer. 2010 Jul;46(11):2036-44
pubmed: 20447824
Scand J Med Sci Sports. 2014 Aug;24 Suppl 1:113-21
pubmed: 24944135
BMJ. 2008 Dec 09;337:a2469
pubmed: 19066253
BMJ Open. 2018 Apr 20;8(4):e022331
pubmed: 29678994

Auteurs

Eik Dybboe Bjerre (ED)

University Hospitals' Centre for Health Research, Rigshospitalet, Copenhagen, Denmark.

Thomas Hindborg Petersen (TH)

University Hospitals' Centre for Health Research, Rigshospitalet, Copenhagen, Denmark.

Anders Bojer Jørgensen (AB)

University Hospitals' Centre for Health Research, Rigshospitalet, Copenhagen, Denmark.

Christoffer Johansen (C)

Unit of Survivorship, Danish Cancer Society Research Center, Copenhagen, Denmark.

Peter Krustrup (P)

Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark.
Sport and Health Sciences, College of Life and Environmental Sciences, University of Exeter, Exeter, United Kingdom.

Bente Langdahl (B)

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.

Mads Hvid Poulsen (MH)

Department of Urology, Odense University Hospital, Odense, Denmark.
Academy of Geriatric Cancer Research, Odense University Hospital, Odense, Denmark.

Søren Sørensen Madsen (SS)

Department of Urology, Hospital of Southwest Denmark/Esbjerg, Esbjerg, Denmark.

Peter Busch Østergren (PB)

Department of Urology, Herlev and Gentofte University Hospital, Herlev, Denmark.

Michael Borre (M)

Department of Urology, Aarhus University Hospital, Aarhus, Denmark.

Mikael Rørth (M)

Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Klaus Brasso (K)

Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Julie Midtgaard (J)

University Hospitals' Centre for Health Research, Rigshospitalet, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH